Current Concepts in Surgical Pathology

Overview

Learn Now: Advances in Surgical Pathology CME

This online CME program presents a broad overview of many areas of surgical pathology designed to update both academic and community pathologists with new advances in the field. Current Concepts in Surgical Pathology provides aids in diagnosis based on conventional morphologic analysis and discusses contemporary applications of immunohistochemical and molecular studies.

This nationally recognized continuing medical education program spans a broad range of surgical pathology areas with 40+ expertly led lectures. Topics include: sinonasal tumors, neoplasms of the liver, cutaneous lymphomas, mucinous tumors of the ovary, perinatal pathology, dermatopathology, testicular neoplasms, follicular thyroid neoplasia, vasculitis, endocervical adenocarcinoma, and more.

PLEASE NOTE: The credit expiration date for this program is February 27, 2025. While you will no longer be able to earn CME credits after that date, you'll have access to the content until February 28, 2027.

Topics / Speakers

Problematic Patterns of In-Situ Breast Carcinoma - Melinda J. Lerwill, MD

Olfactory Neuroblastoma and Other Important Sinonasal Tumors - William C. Faquin, MD, PhD

Extranodal Lymphomas - Judith A. Ferry, MD

Case Presentations: Gastrointestinal Pathology - Angela Shih, MD

Neoplasms of the Liver - Vikram Deshpande, MD, MBBS

Renal Cell Carcinoma: An Update - Kristine Cornejo, MD

Pitfalls in the Diagnosis of Myelodysplastic Syndromes - Robert P. Hasserjian, MD

Indolent and Reactive Mimics of Lymphoma - Judith A. Ferry, MD

Mucinous Tumors of the Ovary - Robert H. Young, MD

Critical Values in Perinatal Pathology - Drucilla J. Roberts, MD

Diffuse Large B-Cell Lymphoma: An Update - Aliyah R. Sohani, MD

Eight Common Reasons for Placental Pathological Examination - Drucilla J. Roberts, MD

Case Presentations: Dermatopathology - Rosalynn M. Nazarian, MD

Update in Diagnostic and Predictive Immunohistochemistry - Ivan A. Chebib, MD

Testicular Neoplasms - Kristine Cornejo, MD

Selected Benign Bladder Lesions - Robert H. Young, MD

Premalignant and Malignant Epithelial Lesions of the Vulva - Jaclyn Watkins, MD, MS

Challenges in Salivary Gland Pathology - William C. Faquin, MD, PhD

Gastrointestinal Polyps - Lawrence R. Zukerberg, MD

Evolving Opportunities in Follicular Thyroid Neoplasia - Peter M. Sadow, MD, PhD

2021 WHO Classification of Lung Tumors - Mari Mino-Kenudson, MD

Case Presentations: Gynecologic Pathology - Jaclyn Watkins, MD, MS

Case Presentations: Gastrointestinal Pathology - 2 - Rory Crotty, MB BCh BAO

Diagnosis of Interstitial Lung Disease: What Clinicians Want to Know - Lida Hariri, MD, PhD

Vasculitis - James R. Stone, MD, PhD

Nipple Lesions - Amy Ly, MD

Fibroepithelial Lesions of the Breast - Melinda J. Lerwill, MD

Autoimmune Liver Disease - Joseph Misdraji, MD

Evaluation of Papillary Breast Lesions - Melinda J. Lerwill, MD

Endocervical Adenocarcinoma: Diagnosis and Subclassification - Esther Oliva, MD

Variant Histology of Urothelial Cancer: Diagnostic Features and Clinical Significance - Chin-Lee Wu, MD, PhD

Case Presentations: Lung Pathology - 1 - Lida Hariri, MD, PhD

Case Presentations: Lung Pathology - 2 - (Yin) Rex Hung, MD, PhD

Neuropathology Frozen Section Interpretation: Problems and Pitfalls - Maria Martinez-Lage, MD

EBV-Associated Lymphoproliferative Disorders - Aliyah R. Sohani, MD

Diagnostic Conundrum of Head & Neck Squamous Mucosal Lesions - Peter M. Sadow, MD, PhD

Pleural and Peritoneal Mesothelioma: Differential Diagnosis - (Yin) Rex Hung, MD, PhD

Problems in the Diagnosis of Uterine Mesenchymal Neoplasms - Esther Oliva, MD

Inflammatory Bowel Disease: Challenges and Controversies - Joseph Misdraji, MD

Pancreatitis and Pancreatic Cancer - Vikram Deshpande, MD, MBBS

Ductal, Intraductal, and Cribriform Carcinoma of Prostate: What Do We Need to Do with Them? - Chin-Lee Wu, MD, PhD

Case Presentations: Gastrointestinal Pathology - 3 - Stuti G. Shroff, MBBS, PhD

Case Presentations: Genitourinary Pathology - Chin-Lee Wu, MD, PhD

Approach to Mistakes, Mix-Ups, and Medico-Legal Messes - Yael K. Heher, MDCM, MPH

Gastritis Beyond H. Pylori - Lawrence R. Zukerberg, MD

Follicular Lymphoma: An Update of a Heterogeneous Neoplasm - Abner Louissaint, Jr., MD, PhD

Germ Cell Tumors of the Ovary - Robert H. Young, MD

Faculty

Accreditation

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Harvard Medical School designates this enduring material for a maximum of 38 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Pathology (ABP)

This activity is approved for 38 credits of Lifelong Learning (Part II) and Self-Assessment Module (SAM) eligible credits towards the American Board of Pathology's Maintenance of Certification Program.

Canadian Accreditation

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

European Accreditation

Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credits™ to an equivalent number of European CME Credits® (ECMEC®s). Information on the process of converting AMA PRA Category 1 Credits™ to ECMEC®s can be found at: www.eaccme.eu.

Date of Original Release: February 28, 2022
Termination Date: February 27, 2025 (Please note that AMA PRA Category 1 Credits™ will no longer be issued for the activity after this date)
Estimated Time to Complete the Activity: 38 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

• Systems-Based Practice
• Medical Knowledge
• Practice-Based Learning and Improvement

Learning Objectives

Upon completion of this activity, participants will be able to apply the following:

• Apply new criteria for pathologic diagnoses in multiple areas of surgical pathology
• Recognize unusual entities
• Evaluate the decision-making process used to arrive at specific diagnoses
• Utilize contemporary tumor classification systems
• Apply immunohistochemistry and/or molecular studies judiciously to establish or confirm diagnoses

Target Audience

This activity is designed for specialty physicians who practice in pathology.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. All individuals in a position to control the content of this activity have been asked to disclose any relationship they have with ineligible companies whose primary business is producing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Disclaimer

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Quick Facts

Provider: Harvard Medical School and Massachusetts General Hospital

Course Directors:
William C. Faquin, MD, PhD
Massachusetts General Hospital

Harvard Medical School

Judith A. Ferry, MD
Massachusetts General Hospital

Harvard Medical School

Melinda J. Lerwill, MD
Massachusetts General Hospital

Harvard Medical School

Robert H. Young, MD
Massachusetts General Hospital

Harvard Medical School

Credits: Earn a maximum of 38 AMA PRA Category 1 Credits™